Bethany Sensenig

Ms. Bethany L.
Sensenig is an Independent Director at Alpha Cognition, Inc., an Independent Director at Supernus Pharmaceuticals, Inc., a Chief Executive & Financial Officer at Naia Rare Diseases LLC and a Chief Financial Officer at CenExel Clinical Research, Inc. She is on the Board of Directors at Supernus, Inc., Alpha Cognition, Inc. and Supernus Pharmaceuticals, Inc. Ms. Sensenig was previously employed as an Independent Director by KalVista Pharmaceuticals, Inc., a Chief Financial Officer & Head-Operations by Radius Health, Inc., a Chief Executive & Financial Officer by 9 Meters Biopharma, Inc., a Chief Financial Officer & Head-US Operations by Minovia Therapeutics Ltd., and a Vice President-Finance & Commercial Operations by Biogen, Inc. She received her undergraduate degree from Montreat College and an MBA from Western Carolina University.